Soluble Guanylate Cyclase (sgc) Modulators For Treatment Of Lipid Related Disorders

  • Published: Oct 16, 2008
  • Earliest Priority: Apr 05 2007
  • Family: 4
  • Cited Works: 0
  • Cited by: 11
  • Cites: 0
  • Additional Info: Full text Published

Disclosed herein are novel compositions and methods for treating or preventing a variety of disorders and conditions associated with lipid metabolism. The methods generally include administering to a patient in need thereof a therapeutically effective amount of a pharmaceutical composition comprising one or more sGC modulators alone or in combination with one or more lipid altering agents and/or PDE inhibitors.

Download PDF
Document Preview
Document History
  • Publication: Oct 16, 2008
  • Application: Apr 3, 2008
    WO US 2008/0059272 W
  • Priority: Apr 5, 2007
    US US 91030907 P

Download Citation

Sign in to the Lens